Evidence map›Paper›PMID 40243724›Full record

ArticleInternational journal of molecular sciences2025

Dual Biopolymer Layer Using Nanoparticles with Active Substance Enclosed in Microcapsules: Innovative Solution for Slow Release of

Przemysław Sitarek, Monika Owczarek, Tomasz Kowalczyk, Wirginia Kukula-Koch, Magdalena Lasoń-Rydel, Lucyna Herczyńska

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Przemysław SitarekDepartment of Medical Biology, Medical University of Lodz, Muszyńskiego 1, 90-151 Lodz, Poland.ORCID 0000-0001-5495-3550
Monika OwczarekŁukasiewicz Research Network-Lodz Institute of Technology, Skłodowskiej-Curie 19/27, 90-570 Lodz, Poland.ORCID 0000-0003-3758-150X
Tomasz KowalczykDepartment of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland.ORCID 0000-0002-4559-5015
Wirginia Kukula-KochDepartment of Pharmacognosy with Medicinal Plants Garden, Medical University of Lublin, Chodzki 1, 20-093 Lublin, Poland.ORCID 0000-0001-7076-600X
Magdalena Lasoń-RydelŁukasiewicz Research Network-Lodz Institute of Technology, Skłodowskiej-Curie 19/27, 90-570 Lodz, Poland.ORCID 0000-0003-3490-2638
Lucyna HerczyńskaTextile Institute, Faculty of Material Technologies and Textile Design, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.ORCID 0000-0003-4278-5988

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dynamic development of various branches of medicine and pharmacy, along with the emergence of new preventive and alternative therapies for various diseases, creates opportunities for new solutions utilizing carriers of active substances. Their therapeutic effect may occur through direct contact with skin lesions or indirectly, where medicinal substances penetrate the capillary network in the deeper layers of the skin and reach the bloodstream. The aim of the research was to obtain carriers with a matrix consisting of two renewable-source polymers (chitosan and ethylcellulose) and a core material derived from

Indexed as

Anti-Bacterial AgentsBiopolymersGinkgo bilobaNanoparticlesCapsulesCelluloseChitosanKineticsKlebsiella pneumoniaeSalmonella enteritidisAnti-Bacterial AgentsBiopolymersCapsulesCelluloseChitosanethyl cellulosebiopolymersdrug releasemathematical modelsmedical applicationsmicrocapsulesnanotechnology

Identifiers

PMID40243724
PMCPMC11988488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.